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Maternal anemia is a well-recognized global health problem; however, there remain questions on specific
hemoglobin (Hb) thresholds that predict health risk or protection for mother and child. We conducted a systematic review and meta-analysis to examine the associations of maternal Hb concentrations with a range of maternal and infant health outcomes, accounting for the timing of measurement (preconception, and first, second, and
third trimesters), etiology of anemia, and cutoff category. The systematic review included 272 studies and the metaanalysis included 95 studies. Low maternal Hb (<110 g/L) was associated with poor birth outcomes (low birth
weight, preterm birth, small-for-gestational-age (SGA), stillbirth, and perinatal and neonatal mortality) and adverse
maternal outcomes (postpartum hemorrhage, preeclampsia, and blood transfusion). High maternal Hb (>130 g/L)
was associated with increased odds of SGA, stillbirth, preeclampsia, and gestational diabetes. Relationships varied by the timing of measurement and cutoff category (stronger associations with lower cutoffs); limited data were
available on anemia etiology. There were insufficient data for other maternal outcomes and long-term child health
outcomes. Current data are insufficient for determining if revisions to current Hb cutoffs are required. Pooled highquality individual-level data analyses, as well as prospective cohort studies, would be valuable to inform the reevaluation of Hb cutoffs.
Keywords: hemoglobin; anemia; pregnancy; review; birth outcomes

Introduction
Anemia is an important global health problem
affecting nearly 529 million women of reproductive
age, including 38% of all pregnant women.1 Anemia
during pregnancy is a key contributor to maternal
mortality and poor birth outcomes in both low- and
high-income countries.2,3 Reducing maternal anemia is widely recognized as central to the health
of women and children. Current WHO global targets call for a 50% reduction of anemia in women of
reproductive age by 2025.4 However, there remain
key gaps in our understanding of the association of
maternal hemoglobin (Hb) concentration on maternal and child health.

Several prior systematic reviews have examined
associations between maternal anemia and birth
outcomes.5–12 Across the studies reviewed, there
is high heterogeneity in the definition of anemia,
the timing of exposure, etiology of anemia, and
in the definitions of normal or healthy reference
ranges for Hb for comparison. Defining anemia
during pregnancy is complicated by changes in Hb
concentrations in response to increases in blood
volume and iron needs of the fetus.13 Hb concentrations reach a low point in the second trimester of
pregnancy due to an increase in plasma volume that
is not equaled by a proportionate increase in red cell
volume expansion. Before 2016, the World Health
Organization (WHO) defined anemia during
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pregnancy as a Hb concentration below 110 g/L
at any time point in the pregnancy.14 However,
2016 WHO recommendations on antenatal care
and the U.S. Centers for Disease Control and Prevention guidelines recommend trimester-specific
cutoffs for anemia (first trimester: <110 g/L; second trimester: <105 g/L; and third trimester:
<110 g/L).15,16 There is a wide range of Hb cutoffs
used across studies, which may affect the likelihood
of detecting relationships with birth outcomes.5
Some studies performed analyses using multiple cutoffs and reported that only more extreme
cutoffs were significantly associated with adverse
birth outcomes.17–20 This is supported by a 2012
meta-analysis of 12 studies which indicated that
moderate to severe, but not mild maternal anemia
was associated with an increased risk of small-forgestational-age (SGA).6 These issues are further
complicated by lack of a clear consensus on normal
or healthy reference ranges for Hb.
The timing of the measurement of maternal anemia is also variable across studies. This is problematic for meta-analyses, as existing literature suggests
a differential impact of maternal Hb concentration
depending on the timing during pregnancy.5 For
low Hb concentration, the link with adverse birth
outcomes is more evident when Hb concentration
is measured in early pregnancy.19–21 As summarized
in a recent review, several studies have observed a
U-shaped curve for the risk of adverse birth outcomes with maternal Hb, that is, there is a higher
risk of adverse outcomes among women with both
low and high Hb concentrations.5 However, the
consistency of this relationship varies based on the
trimester of Hb assessment. High Hb concentration could be a marker of inadequate plasma volume
expansion, which is likewise associated with adverse
birth outcomes.5 Further research is needed to better understand these relationships; however, there is
also a lack of consensus on the cutoff to define high
Hb concentration, making it difficult to study how
high Hb concentration relates to maternal and child
health outcomes.
In addition to the important role of the timing
during pregnancy, there is a growing emphasis
on the importance of maternal nutritional status
and anemia before pregnancy.22–25 Compared with
pregnancy, much less is known about the influence
of maternal preconception Hb concentration on
health outcomes.
48
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Finally, the etiology of anemia is diverse, and it
remains unclear how the relationship between anemia and maternal and child outcomes varies by
cause of anemia. Scholl et al. report greater odds
of both low birth weight and preterm birth associated with iron deficiency anemia (IDA) compared
with non-IDA.26 It is estimated that approximately
50% of anemia among nonpregnant and pregnant
women is responsive to iron supplementation;27
however, at the national and subnational level, the
percentage of anemia that is IDA has been shown to
be extremely variable, ranging from <1% to 75%.28
Whether the etiology of anemia affects relationships
between Hb concentrations and health outcomes
merits closer examination.
Given the importance of maternal anemia across
the globe, it is critical to come to a consensus on the
definition of maternal anemia and whether it needs
to account for the timing during pregnancy and
etiology.
Our objective was to conduct a systematic review
and meta-analysis on the associations of maternal
Hb concentrations with a range of maternal and
infant health outcomes, accounting for the timing
of measurement (preconception, and first, second,
and third trimesters), etiology of anemia, and cutoff
category to inform WHO guidelines on Hb concentration cutoffs.
Methods
Search strategy
We searched for studies that reported associations
between maternal Hb concentrations or anemia,
measured during preconception or pregnancy, and
a range of maternal and child outcomes. Maternal outcomes included postpartum hemorrhage,
preeclampsia, blood transfusion, prenatal and postpartum depression, and maternal mortality. Child
health outcomes included both birth and long-term
outcomes, such as low birth weight (LBW; birth
weight <2500 g), SGA (birth weight below the 10th
percentile for gestational age or as defined by study
authors), preterm birth (PTB; <37 weeks of gestation), stillbirth (as defined by study authors, e.g.,
fetal death, fetal death at or after 28 weeks gestation,
birth of fetus at 22 gestational weeks, or later with
no signs of life), perinatal mortality (defined as the
sum of fetal deaths (28 weeks or more gestation) and
infant deaths occurring less than 7 days after birth),
neonatal mortality (death within first 28 days of
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life), infant mortality (death within the first year of
life), birth weight and length, head circumference,
child development, diabetes, hypertension, blood
pressure, and cardiovascular disease. With the help
of the Emory University Library staff, we searched
PubMed and Cochrane Review in June 2017 and
updated the search in October 2018 with no restrictions for language, date, or population (Table S1,
online only). Reference lists from previous systematic reviews were also screened to identify any studies not initially included in our search strategy.
Studies were eligible for inclusion in the systematic review and meta-analysis if they reported an
association between maternal Hb concentration or
anemia, during preconception or pregnancy, and
one or more of the above key outcomes. We limited the meta-analyses to peer-reviewed studies that
adjusted for one or more confounders.
Data extraction and quality assessment
Screening and article selection was conducted
using Covidence systematic review software (Veritas Health Innovation, Melbourne, Victoria,
Australia) to organize search results from PubMed
and Cochrane Review. The abstract screening
was independently completed in duplicate by two
authors and conflicts were reviewed and resolved
by a third member. A full-text review was likewise
completed in duplicate by two team members and
conflicts were resolved by a committee of five team
members. Data extracted included country, year
of study, study design, study participant characteristics, the timing of exposure, Hb measurement,
outcomes, iron status/deficiency, infection status,
Hb laboratory method, confounders, and the measure of association. A back check on 10% of all
data extractions was conducted by a second team
member. We attempted to contact corresponding
authors for any missing data not presented in the
publication (e.g., definition of anemia, the timing of
measurement, included covariates, or the measure
of association).
Data management and analyses
Selected characteristics and results of included
studies were abstracted including country, year of
study, study design, the timing of measurement,
outcome measure, covariates, and an adjusted and
unadjusted measure of associations with 95% confidence intervals. For the meta-analysis, data were
stratified by the timing of measurement: preconcep-
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tion, first trimester (≤13 weeks), second trimester
(14−26 weeks), and third trimester (≥27 weeks).
Studies in which the timing of Hb concentration
was unclear (e.g., the lowest Hb concentration during pregnancy and Hb concentration at enrollment
without specifying gestational age at enrollment)
or unrestricted were only considered in the overall
pregnancy estimate. Maternal Hb concentration
was examined both as a continuous and a categorical variable (as defined in the publications).
Because evidence suggests that the association
between maternal Hb concentrations and outcomes
is not linear, meta-analyses using continuous Hb
measures are difficult to summarize and interpret;
thus, data from these studies are presented in a table
format only. Summary estimates by the timing were
constructed using all low Hb cutoffs (<110 g/L)
and all high Hb cutoffs (>130 g/L). Definitions of
anemia and elevated Hb varied across studies, thus
separate analyses were conducted by cutoff used
(≤70, ≤80, ≤90, ≤100, ≤110, ≥120, ≥130, and
≥140 g/L) to create summary estimates. Categories
were cumulative, for example, the ≤100 g/L category included studies using the ≤100g/L cutoff or
any subset where all Hb values were ≤100 g/L. Definitions of study exposure for all studies included
in the meta-analysis are summarized in Tables
S2−S5 (online only). Reference groups varied
and are specified for all studies included in the
meta-analysis in Figures S1–S10 (online only). It is
important to note that the reference groups varied
widely across studies, with some providing a range
(e.g., 110−119 g/L) and others a cut off (≥110 g/L)
with little consensus on what represents a “healthy”
reference value. Where data were available, stratified analyses were conducted specifically for iron
deficiency (ID) and by the level of reported baseline maternal ID. Meta-analyses were performed
if there were at least three studies with the same
exposure, outcome, study design, and timing. All
analyses were done using STATA version 14.2
(Stata Corp. 2015, College Station, TX) using the
“admetan” command. Heterogeneity was assessed
by Q- and I2 -statistics. I2 values over 50% and a
Q-statistic P value of >0.10 indicated substantial
heterogeneity among studies. As most analyses
showed significant heterogeneity, all meta-analyses
were conducted using random effects models and
the inverse-variance method for weighting. Results
were considered statistically significant if P < 0.05.
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Figure 1. Flow of study selection.

Results
Our search strategy identified 7677 studies in October 2018, of which 46 duplicates were removed
(Fig. 1). Abstracts of 7631 studies were screened for
eligibility based on inclusion and exclusion criteria.
We completed a full text review on 560 studies; and
307 studies were excluded on the basis of inclusion and exclusion criteria (n = 293), inability to
translate (n = 9), duplication of study results (n =
1), or unavailable full text (n = 4). We included an
additional 19 studies missed by our search strategy
by reviewing the reference lists of prior systematic
reviews. In total, 272 studies were included in our
review and 95 studies met the criteria for inclusion
in the meta-analyses (Fig. 1),17,21,26,29–121 while the
remaining 177 studies are summarized in table format only. A summary of all studies included in the
meta-analyses is provided in Table S2 (online only).
Additional child health outcome data are summarized in Table S3 (online only) for outcomes with
too few studies to conduct a meta-analysis and in
Table S6 (online only) for outcomes that met inclusion criteria but used statistical measures incompatible with pooling in meta-analyses. Likewise, additional maternal health outcome data are presented
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in Table S4 (online only) for maternal outcomes
with an inadequate number of studies to conduct
a meta-analysis and in Table S7 (online only) for
studies using statistical measures incompatible with
pooling. Studies conducted in high-risk populations are presented in Table S5 (online only). Based
on available data presented for certain outcomes of
interest in studies, 24 studies were included in both
the meta-analyses and narrative review.
Study characteristics
Of the 95 studies included in the meta-analyses,
there were 23 prospective cohorts, 36 retrospective
cohorts, 27 case–control, and 9 cross-sectional studies. Studies were published from 1984 to 2018 and
took place in 37 countries. Included studies come
from all six WHO geographical regions: Southeast
Asia (n = 16), Europe (n = 21), Western Pacific
(n = 17), the Americas (n = 13), Africa (n = 14),
and Eastern Mediterranean (n = 10). Four large
multicenter studies were conducted in multiple
WHO regions; one study was conducted in four
high-income countries across the European and
Western Pacific regions,69 one was conducted in
24 countries across the regions of Africa, Southeast Asia, and the Americas,37 one was conducted
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in 16 countries across the regions of the Eastern Mediterranean, Africa, Southeast Asia, and the
Americas,118 and another was conducted in 29
countries across the African, Southeast Asian, Eastern Mediterranean, and Western Pacific regions.76
Study sample sizes ranged from 102 to 2,722,274,
and maternal age, education level, body mass index,
and parity were commonly adjusted for in statistical analyses. Presented results are limited to childbirth and maternal health outcomes as there were
insufficient data to assess long-term outcomes, such
as a chronic disease in the meta-analyses. Only
four studies measured preconception Hb concentrations: Ronnenberg et al., Zhang et al., and Yi et al.
measured Hb concentrations a median of 5 weeks
prior to conception, 1.5 months prior to conception, and on or before the first day of the last menstrual cycle, respectively, while the preconception
timing for Maghsoudlou et al. is unclear (1 year
before pregnancy).17,82,98,111
Child health outcomes
Data were available to conduct meta-analyses for
the following birth outcomes: (1) low birth weight
(n = 41); (2) preterm birth (n = 40); (3) small for
gestational age (n = 25); (4) stillbirth (n = 19);
(5) perinatal mortality (n = 11); and (6) neonatal mortality (n = 5). Results for these outcomes
are presented by (1) time period: preconception,
and first, second, and third trimesters; (2) cutoff: Hb ≤70, ≤80, ≤90, ≤100, ≥120, ≥130, and
≥140 g/L; and (3) overall estimate throughout pregnancy analysis (when data were available for each
comparison). Table 1 summarizes associations with
low maternal Hb and child outcomes and Table 2
summarizes associations with high maternal Hb.
Several studies included in our review used statistical methods incompatible with the inclusion in
the overall meta-analyses; these studies are summarized in Table S6 (online only). Data were stratified by Hb cutoff and timing. There were insufficient
data to further examine Hb cutoff within each of
the trimesters, so these two factors were examined
separately. In the tables, blank cells indicate that
no studies explored the association and estimates
with an asterisk were based on only 1−2 studies.
The number of individual studies assessing maternal Hb concentration and birth outcomes in the
meta-analyses for each Hb concentration is summarized in Table S8 (online only).
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Low birth weight
Hb cutoff. Summary estimates were constructed
by Hb concentration cutoff: ≤70, ≤80, ≤90,
≤100, ≤110, ≥120, ≥130, and ≥140 g/L (Fig.
2A). There was a dose−response relationship
between low maternal Hb concentration and the
odds of delivering an LBW infant (≤70 g/L:
OR (95% CI); 2.97 (1.85−4.75); ≤80 g/L: 2.77
(1.91−4.02); ≤90 g/L: 2.48 (1.90−3.23); ≤100 g/L:
1.49 (1.33−1.67); ≤110 g/L: 1.42 (1.31−1.55))
(Table 1). Point estimates for the odds of LBW associated with elevated Hb concentrations were not statistically significant (≥120 g/L: OR (95% CI); 1.41
(0.94−2.13); ≥130 g/L: 1.61 (0.82−3.16); ≥140 g/L:
1.37 (0.44−4.23); ≥150 g/L: 0.78 (0.19−3.18);
≥160 g/L: 0.78 (0.19−3.18)) (Table 2).
Timing. Estimates from studies examining low
Hb concentration (any definition: ≤110 g/L or
lower) were divided based on the timing of measurement (preconception, first, second, and third
trimesters, and overall (during pregnancy)) (Table 1
and Fig. S11, online only). Overall, low Hb concentration measured at any time point was associated
with an increased risk of LBW (preconception:
OR (95% CI); 1.72 (1.31−2.26); first trimester: OR
(95% CI); 1.23 (1.07−1.41); second trimester: OR
(95% CI); 1.14 (0.78−1.68); third trimester: OR
(95% CI); 1.65 (1.39−1.96)). Only in the second
trimester was this relationship not statistically
significant. Low Hb concentration during the preconception period had the strongest association
with increased odds of LBW, but this estimate was
based on limited data (Table 1).
Elevated Hb concentration was not significantly
associated with LBW when measured preconception or in the first trimester (Table 2 and Fig. S12,
online only). In the second trimester, there were
increased odds of LBW associated with high maternal Hb and in the third trimester decreased odds
of LBW; however, these results are based on limited
data (<3 studies) and should be interpreted with
caution.
Overall estimate. In a meta-analysis of all studies
during pregnancy (n = 36), low maternal Hb was
associated with increased odds of LBW (OR (95%
CI); 1.42 (1.31−1.55)) (Table 1). High maternal Hb
(n = 5) was not significantly associated with LBW,
though there was a similar trend (OR (95% CI); 1.80
(0.86−3.77)) (Table 2).
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Table 1. Meta-analysis of the association between low maternal Hb and child outcomes
LBW OR
(95% CI)

PTB OR
(95% CI)

SGA OR
(95% CI)

Timing: low maternal Hb (<110 g/L) by timing
Preconception
1.72
1.04
1.79
(1.31−2.26)*
(0.97−1.12)
(1.39−2.31)*
First trimester
1.23
1.28
1.08
(1.07−1.41)
(1.17−1.40)
(0.94−1.25)
Second trimester
1.14
1.37
1.14
(0.78−1.68)
(1.15−1.63)
(0.96−1.37)
Third trimester
1.65
1.45
0.90
(1.39−1.96)
(1.23−1.71)
(0.73−1.10)
Cutoff: low maternal Hb at any time during pregnancy by cutoff
≤70 g/L
2.97
3.72
1.29
(1.85−4.75)
(1.53−9.03)*
(1.15−1.43)*
≤80 g/L
2.77
2.89
1.39
(1.91−4.02)
(1.71−4.89)
(1.22−1.60)
≤90 g/L
2.48
1.73
1.32
(1.90−3.23)
(1.38−2.16)
(1.20−1.44)
≤100 g/L
1.49
1.47
1.13
(1.33−1.67)
(1.32−1.65)
(1.01−1.27)
≤110 g/L
1.42
1.36
1.08
(1.31−1.55)
(1.26−1.46)
(1.00−1.18)
1.42
1.36
1.08
Overall estimate**
<110 g/L
(1.31−1.55)
(1.26−1.46)
(1.00−1.18)

Stillbirth OR
(95% CI)

Perinatal
mortality OR
(95% CI)

Neonatal
mortality OR
(95% CI)

1.23
(0.39−3.86)*
1.42
(0.39−5.25)*
2.22
(1.36−3.65)
1.82
(0.97−3.42)

1.61
(0.80−3.24)
1.38
(0.88−2.15)*
1.27
(0.97−1.67)

3.13
(1.76−5.57)*

3.87
(1.88−8.06)
2.84
(1.27−6.37)
2.47
(1.52−4.01)
1.88
(1.27−2.78)
1.49
(1.15−1.92)
1.49
(1.15−1.92)

4.41
(2.21−8.81)*
3.82
(2.34−6.24)
2.66
(1.28−5.55)
1.94
(1.38−2.47)
1.73
(1.32−2.26)
1.73
(1.32−2.26)

1.10
(0.29−4.21)*
1.10
(0.29−4.21)*
1.57
(1.19−2.08)
1.49
(1.19−1.87)
1.49
(1.19−1.87)

Notes: The sample size for individual studies is provided in Table S2 (online only), and the total number of studies included in each
Hb cutoff effect estimate and timing are specified in Table S8 (online only). A number of studies included for an overall estimate
(<110 g/L): LBW (36), PTB (33), SGA (21), stillbirth (21), perinatal mortality (11), and neonatal mortality (5). Reference groups for
individual studies included in the meta-analysis were highly variable, with some providing a range (e.g., 110−119 g/L) and others a
cut off (≥110 g/L), with little consensus on what represents a “healthy” reference value. Reference groups for all studies included in
meta-analyses can be found in Figures S1–S6 (online only). Categories are cumulative; for example, the ≤100 g/L category includes
studies using the ≤100 g/L cutoff or any subset where all Hb values were ≤100 g/L. Definitions: LBW, low birth weight (<2500 g); PTB,
preterm birth (birth at <37 weeks gestation); SGA, small for gestational age (birth weight below the 10th percentile for gestational
age or as defined by study authors); stillbirth (as defined by study authors); perinatal mortality (defined as the sum of fetal deaths
(28 weeks or more gestation), and infant deaths occurring less than 7 days after birth); neonatal mortality (death within 28 days of
life); first trimester: ≤13 weeks; second trimester: 14–26 weeks; third trimester: ≥27 weeks. Bold values are statically significant with
P < 0.05.
* Summary estimates from meta-analyses of <3 studies.
** Overall estimates using Hb concentrations measured at any point during pregnancy.

Preterm birth
Hemoglobin cutoff. Overall, low Hb concentration was significantly associated with higher odds of
PTB, with larger odds ratios seen with lower cutoffs
(≤70 g/L: OR (95% CI); 3.72 (1.53−9.03); ≤80 g/L:
2.89 (1.71−4.89); ≤90 g/L: 1.73 (1.38−2.16);
≤100 g/L: 1.47 (1.32−1.65); ≤110 g/L: 1.36
(1.26−1.46)) (Fig. 2B and Table 1). None of
the odds ratios with regard to high Hb concentration were statistically significant (≥120 g/L:
OR (95% CI); 1.16 (0.97−1.38); ≥130 g/L: 1.14
52

(0.95−1.37); ≥140 g/L: 1.10 (0.84−1.46); ≥150 g/L:
1.01 (0.55−1.85); ≥160 g/L: 0.42 (0.14−1.29))
(Fig. 2B and Table 2).
Timing. Summary estimates were constructed
according to the timing of Hb measurement
(Table 1). Results for preconception Hb and odds
of PTB were nonsignificant; however, they were in
a similar direction as observed during pregnancy,
although based on limited data. When studies
were divided by trimester of measurement, low Hb
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Table 2. Meta-analysis of association between high maternal Hb and child outcomes
LBW OR (95% CI)

PTB OR (95% CI)

Timing: high maternal Hb (>130 g/L) by timing
Preconception
1.04 (0.93−1.16)*
1.06 (1.00−1.13)*
First trimester
1.34 (0.52−3.46)*
0.93 (0.84−1.03)
Second trimester
1.40 (1.02−1.93)*
1.07 (0.83−1.39)
Third trimester
0.58 (0.45−0.74)*
0.92 (0.55−1.56)*
Cutoff: high maternal Hb at any time during pregnancy by cutoff
1.41 (0.94−2.13)
1.16 (0.97−1.38)
≥120 g/L**
≥130 g/L
1.61 (0.82−3.16)
1.14 (0.95−1.37)
≥140 g/L
1.37 (0.44−4.23)
1.10 (0.84−1.46)
1.01 (0.55−1.85)
≥150 g/L
0.78 (0.19−3.18)*
≥160 g/L
0.78 (0.19−3.18)*
0.42 (0.14−1.29)*
Overall estimate*** >130 g/L
1.80 (0.86−3.77)
1.17 (0.94−1.45)

SGA OR (95% CI)

Stillbirth OR (95% CI)

1.03 (0.97−1.10)*
1.12 (0.99−1.27)
1.54 (1.31−1.81)*
1.08 (0.92−1.27)*

0.83 (0.52−1.33)*
1.28 (0.96−1.70)*

1.19 (1.08−1.31)
1.22 (1.10−1.35)
1.18 (0.97−1.42)
0.92 (0.55−1.56)*
0.61 (0.22−1.56)*
1.22 (1.08−1.37)

2.31 (1.30−4.10)*
1.38 (1.11−1.73)
1.59 (1.14−2.22)
2.30 (1.38−3.85)

1.88 (1.21−2.91)

Notes: The sample size for individual studies is provided in Table S2 (online only), and the total number of studies included in each
Hb cut-off effect estimate and timing are specified in Table S8 (online only). A number of studies included for an overall estimate
(>130): LBW (5), PTB (10), SGA (4), and stillbirth (4). Reference groups for individual studies included in the meta-analysis were
highly variable, with some providing a range (e.g., 110−119 g/L) and others a cut off (≥110), with little consensus on what represents
a “healthy” reference value. Reference groups for all studies included in meta-analyses can be found in Figures S1−S4 (online only).
Categories are cumulative; for example, the ≥140 g/L category includes studies using the ≥140 g/L cutoff or any subset where all Hb
values were ≥140 g/L. Definitions: LBW, low birth weight (<2500 g); PTB, preterm birth (birth at <37 weeks gestation); SGA, smallfor-gestational-age (birth weight below the 10th percentile for gestational age or as defined by study authors); stillbirth (as defined
by study authors); perinatal mortality (defined as the sum of fetal deaths (28 weeks or more gestation) and infant deaths occurring
less than 7 days after birth); first trimester: ≤13 weeks; second trimester: 1–26 weeks; third trimester: ≥27 weeks. Bold values are
statically significant with P < 0.05.
* Summary estimates from meta-analyses of <3 studies.
** Summary estimates for ≥120 g/L presented, but high Hb defined as ≥130 g/L for inclusion in meta-analysis summary estimates.
*** Overall estimates using Hb concentrations measured at any point during pregnancy.

concentration in each trimester was associated with
increased odds of PTB (first trimester: OR (95% CI);
1.28 (1.17−1.40); second trimester: OR (95% CI);
1.37(1.15−1.63); third trimester: OR (95% CI); 1.45
(1.23−1.71)) (Table 1 and Fig. S13, online only).
High Hb concentrations were not significantly associated with PTB, regardless of the timing of measurement (Table 2 and Fig. S14, online only).
Overall estimate. When studies including all
time points and cutoffs were pooled across pregnancy, low Hb concentration (n = 33) was significantly associated with increased odds of PTB
(OR (95% CI); 1.36 (1.26−1.46)) but high Hb concentration (n = 10) was not (OR (95% CI); 1.17
(0.94−1.45)) (Tables 1 and 2).
Small for gestational age
Hemoglobin cutoff. Summary estimates for the
associations with SGA were constructed according to Hb concentration cutoffs (Fig. 2C, and
Tables 1 and 2). The strongest relationships were
evident at the lowest Hb concentration cutoffs

of ≤80 g/L (OR (95% CI); 1.39 (1.22−1.60))
and ≤90 g/L (1.32 (1.20−1.44)). More modest associations were observed with cutoffs of
≤100 g/L (1.13 (1.01−1.27)) and ≤110 g/L (1.08
(1.00−1.18)). Data were limited for higher cutoffs
of Hb concentration and are presented in Table 2;
in brief, high Hb concentrations were also associated with increased odds of SGA (OR (95% CI):
≥130 g/L: 1.22 (1.10−1.35)). Results for higher cutoffs (≥140−≥160 g/L) were nonsignificant.
Timing. Tables 1 and 2 summarize the results
regarding the timing of measurement of maternal
Hb concentration, with respect to SGA. Overall,
preconception low Hb concentration was associated with increased odds of SGA (OR (95% CI);
1.79 (1.39−2.31)) and high Hb concentration was
not (1.03 (0.97−1.10)); however, data were very
limited. When divided by the trimester of pregnancy, low maternal Hb concentration was not significantly associated with SGA in any trimester
(see Fig. S15, online only). High maternal Hb
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Figure 2. Meta-analysis summary estimates of association of maternal hemoglobin concentration (g/L) measured at any point
during pregnancy and LBW, PTB, and SGA by hemoglobin concentration cutoffs.
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concentration was not associated with increased
odds of SGA in the first or third trimester, but limited data from two studies suggest that high maternal Hb concentration in the second trimester was
associated with increased odds of SGA (OR (95%
CI); 1.54 (1.31−1.81)) (see Fig. S16, online only).
Overall estimate. Overall, both low (n = 21)
and high (n = 4) maternal Hb concentrations
were associated with increased odds of SGA (OR
(95% CI); 1.08 (1.00−1.18) and 1.22 (1.08−1.37),
respectively).
Stillbirth
Hemoglobin cutoff. The relationship between
maternal Hb cutoff and stillbirth is summarized in
Figure 3A, and Tables 1 and 2. A dose response was
evident, with lower cutoffs being associated with
greater odds of stillbirth (≤70 g/L: OR (95% CI);
3.87 (1.88−8.06); ≤80 g/L: 2.84 (1.27−6.37);
≤90 g/L: 2.47 (1.52−4.01); ≤100 g/L: 1.88
(1.27−2.78); ≤110 g/L: 1.49 (1.15−1.92)). High Hb
concentrations were also related to elevated odds
of stillbirth (≥120 g/L: 1.38 (1.11−1.73); ≥130 g/L:
1.59 (1.14−2.22); ≥140 g/L: 2.30 (1.38−3.85)).
Timing. Only one study (Maghsoudlou et al.)
examined the relationship of preconception Hb to
stillbirth, with results indicating no significant associations with low (OR (95% CI); 1.23 (0.39−3.86)
or high (0.83, (0.52−1.33)) Hb concentrations.17
During pregnancy, low maternal Hb in the second
trimester was associated with increased odds of stillbirth (OR (95% CI); 2.22 (1.36−3.65)). Although
associations were nonsignificant for the first and
third trimesters, there was a similar trend of elevated odds of stillbirth. The study by Maghsoudlou et al. examined the association between high
maternal Hb measured during the third trimester
and stillbirth; results indicated increased odds
of stillbirth with high Hb (OR (95% CI); 2.31
(1.30−4.10)).17
Overall estimate. The relationship between low
Hb concentration (n = 21) and stillbirth, with all Hb
cutoffs and times during pregnancy combined, was
significant (OR (95% CI); 1.49 (1.15−1.92)), and the
same was true for high Hb (n = 4) (OR (95% CI);
1.88 (1.21−2.91)) (Tables 1 and 2).
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Perinatal mortality
Hemoglobin cutoff. Relationships between low
maternal Hb concentrations and perinatal mortality are summarized in Table 1 and Figure 3B.
There were elevated odds of perinatal mortality
associated with Hb ≤70 g/L (OR (95% CI); 4.41
(2.21−8.81)), ≤80 g/L (3.82 (2.34−6.24)), ≤90 g/L
(2.66 (1.28−5.55)), ≤100 g/L (1.94 (1.38−2.47)),
and ≤110 g/L (1.73 (1.32−2.26)). There were
insufficient data available to examine associations
between high Hb concentrations and perinatal
mortality.
Timing. There were limited data on the timing of Hb assessment. While trimester-specific
results were nonsignificant, there was a consistent
trend for increased perinatal mortality associated
with low maternal Hb across pregnancy (Table 1).
Insufficient data were available on the relationship
between high maternal Hb and perinatal mortality.
Overall estimate. When data across time points
(including studies in which the timing was not
defined) and cutoffs were combined, low maternal
Hb (n = 11) was associated with increased odds of
perinatal mortality (OR (95% CI); 1.73 (1.32−2.26))
(Table 1).
Neonatal mortality
Hemoglobin cutoff. Summary estimates for odds
of neonatal mortality by Hb cutoff were constructed
(Fig. 3C and Table 1). A Hb ≤100 g/L was associated
with increased odds of neonatal mortality (OR (95%
CI); 1.57 (1.19−2.08)) as was a Hb ≤110 g/L (1.49
(1.19−1.87)). There were limited data for lower Hb
cutoffs or high Hb concentrations.
Timing. Only one study that reported neonatal mortality also reported the time of Hb measurement: Thakur et al. measured Hb in the
first trimester and found a significant association
between maternal Hb <100 g/L and neonatal mortality (OR (95% CI); 3.13 (1.76−5.57)) (Table 1).93
Overall estimate. When all time points and cutoff values were combined, low maternal Hb (n = 5)
was associated with increased odds of neonatal
mortality (OR (95% CI); 1.49 (1.19−1.87)). There
were insufficient data to examine the relationship
between high maternal Hb and neonatal mortality.
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Figure 3. Meta-analysis summary estimates of association of maternal hemoglobin concentration (g/L) measured at any point
during pregnancy and stillbirth, perinatal mortality, and neonatal mortality by hemoglobin concentration cutoffs.
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Table 3. Meta-analysis summary estimates of association of IDA and non-IDA with birth outcomes
Outcome

IDA OR (95% CI)

Non-IDA OR (95% CI)

LBW
SGA
PTB

1.17 (0.95−1.43)
0.77 (0.68−0.87)

1.43 (0.82−2.50)
1.20 (0.85−1.70)
1.07 (0.68−1.70)

LBW: IDA: n = 2; non-IDA: n = 3; SGA: IDA: n = 2; non-IDA:
n = 4; PTB: non-IDA: n = 4.

Anemia etiology
Overall, very few studies distinguished between
IDA and non-IDA in relation to maternal and child
functional outcomes. Data were only available for
birth outcomes including LBW, preterm birth, and
SGA; summary estimates are provided in Table 3.
Summary estimates for the association of LBW with
IDA and non-IDA were both positive but not statistically significant.
There was an insufficient number of studies that
examined IDA in relation to PTB birth to merit a
meta-analysis. Four studies examined anemia and
PTB in non-IDA populations or in populations
with a low prevalence of IDA. The pooled estimate
showed a nonsignificant relationship between anemia and PTB (OR (95% CI); 1.07 (0.68−1.70)).
Based on two studies examining the association between IDA and SGA,26,46 there were
decreased odds of SGA with IDA (OR (95% CI);
0.77 (0.68−0.87)). Four studies examined the association between SGA and non-IDA or anemia in
a population with a low prevalence of ID, and the
overall estimate showed no significant association
(OR (95% CI); 1.20 (0.85−1.70)).
Data on anemia etiology were not available for
stillbirth, perinatal mortality, or neonatal mortality.
Other child health outcomes
There were too few studies (n < 3) to conduct metaanalyses for several child health outcomes of interest: sudden infant death syndrome (n = 1), infant
mortality (defined as death before 1 year of life)
(n = 1), allergic sensitization (n = 1), and type I
diabetes (n = 1). For several other child health outcomes of interest, there were ≥3 studies but the
available studies had insufficient or poor quality
data, so meta-analyses were not conducted; these
included cardiovascular outcomes (n = 8), child
development (n = 6), child morbidities (n = 5), and
schizophrenia (n = 3). Summaries of these studies

(including setting, study design, sample size, exposure, the timing of exposure, and effect estimate) are
provided in Table S3 (online only).
Maternal health outcomes
While much of the research examining maternal
Hb concentrations has focused on health implications for the infant, there is a growing interest
regarding maternal health outcomes. Below, we
report on the associations between maternal Hb
concentrations and selected maternal health outcomes. We provide meta-analyses results when
possible (postpartum hemorrhage (n = 7), transfusion (n = 4), preeclampsia (n = 9), and gestational
diabetes (n = 4)) and summarize results in Table 4.
In addition, several studies included in our review
used statistical methods incompatible with the
inclusion in the overall meta-analyses; these studies
are summarized in Table S7 (online only). For
several outcomes, there was an insufficient number
of studies for several outcomes for meta-analyses,
and only a qualitative summary is provided (see
Table S4, online only). A summary of the number
of studies included in each of the meta-analyses is
provided in Table S9 (online only).
Postpartum hemorrhage
A total of six studies examined the association of
maternal hemorrhage with anemia and one study
looked at maternal hemorrhage in relation to high
Hb concentrations.
Hemoglobin cutoff. Summary estimates were
constructed to examine the association between
postpartum hemorrhage and Hb using different cutoffs (Table 4). Low Hb concentration was
significantly associated with postpartum hemorrhage, with the greatest odds with the lowest
cutoffs (≤70 g/L: OR (95% CI); 6.15 (3.86−9.79))
compared to higher cutoffs (≤110 g/L: 1.84
(1.42−2.37)). One study examined the association between high Hb and postpartum hemorrhage
and reported no significant association (OR (95%
CI); 0.84 (0.67−1.05)).
Timing. Only two studies specified the time of
measurement of Hb when examining the association with postpartum hemorrhage. Both studies
measured Hb in the third trimester and overall
found higher odds of postpartum hemorrhage with
low maternal Hb (OR (95% CI); 1.39 (1.12−1.72)).
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Table 4. Meta-analyses of association between maternal Hb concentrations and maternal outcomes by Hb concen-

tration cutoffs
PPH OR (95% CI)

Preeclampsia OR (95% CI)

Cutoff: maternal Hb at any time during pregnancy by cutoff
2.83 (2.08−3.85)
≤70 g/L
6.15 (3.86−9.79)*
≤80 g/L
6.15 (3.86−9.79)*
2.83 (2.08−3.85)
≤90 g/L
4.02 (2.66−6.07)
2.30 (1.31−4.03)
≤100g/L
2.40 (1.47−3.93)
1.93 (1.33−2.80)
≤110 g/L
1.84 (1.42−2.37)
1.68 (1.20−2.35)
Overall estimate** <110 g/L
1.84 (1.42−2.37)
1.84 (1.31−2.59)
≥120 g/L
0.84 (0.67−1.05)*
1.64 (1.24−2.18)
1.34 (1.16−1.56)*
≥130 g/L
0.84 (0.67−1.05)*
1.58 (0.88−2.83)*
≥140 g/L
0.84 (0.67−1.05)*
**
*
Overall estimate >130 g/L
0.84 (0.67−1.05)
1.48 (1.10−2.01)

Transfusion OR (95% CI)
43.46 (22.06−85.62)*
24.75 (8.15−75.15)*
13.96 (3.85−50.63)*
7.70 (2.48−23.86)
6.57 (3.59−12.00)
6.57 (3.59−12.00)

GDM

0.92 (0.73−1.16)*
0.92 (0.73−1.16)*
1.93 (1.33−2.81)
1.71 (1.19−2.46)
2.10 (1.65−2.68)*
2.02 (1.63−2.50)

Notes: The sample size for individual studies is provided in Table S2 (online only), and the total number of studies included in each
Hb cutoff effect estimate and timing are specified in Table S9 (online only). A number of studies included for overall estimates for low
Hb (<110 g/L) are PPH (6), preeclampsia (8), transfusion (4), GDM (2), and for high Hb (>130 g/L) are PPH (1), preeclampsia (3),
and GDM (4). Reference groups for individual studies included in the meta-analysis were highly variable, with some providing a range
(e.g., 110−119 g/L) and others a cut off (≥110 g/L), with little consensus on what represents a “healthy” reference value. Reference
groups for all studies included in meta-analyses can be found in Figures S7–S10 (online only). Reference groups for all studies included
in meta-analyses can be found in Figures S1–S6 (online only). Categories are cumulative; for example, the ≤100 g/L category includes
studies using the ≤100 g/L cutoff or any subset where all Hb values were ≤100 g/L. Bold values are statically significant with P < 0.05.
* Summary estimates from meta-analyses of <3 studies. Note, for PPH outcome, one study contributes data to the high Hb cutoffs
and overall estimate and one study contributes to the lowest Hb cutoffs (≤70 and ≤80 g/L).
** Estimates using Hb concentrations measured at any point during pregnancy.
PPH, postpartum hemorrhage; GDM, gestational diabetes mellitus.

Overall estimate. When all time points and cutoffs were combined, low Hb (n = 6) was associated
with increased odds of postpartum hemorrhage
(OR (95% CI); 1.84 (1.42−2.37)). There were insufficient data for the association between high Hb
and postpartum hemorrhage.
Transfusion
Hemoglobin cutoff. Four studies were included
on transfusion, an indicator of severe blood loss
at delivery, and low maternal Hb. Associations are
reported for cutoffs ≤100 g/L (OR (95% CI); 7.70
(2.48−23.86)) and ≤110 g/L (6.57 (3.59−12.00))
(Table 4). Estimates for lower cutoffs were substantially higher (≤70 g/L: OR (95% CI); 43.46
(22.06−85.62)) but based on limited data (<3
studies).
Timing. Data to examine the timing of Hb measurement were not available.
Overall estimate. Overall, across pregnancy low
Hb (n = 4) was associated with increased odds of
receiving a blood transfusion (OR (95% CI); 6.57
(3.59−12.00)) (Table 4).
58

Preeclampsia
Hemoglobin cutoff. Low Hb was significantly
associated with higher odds of preeclampsia
(≤70 g/L: OR (95% CI); 2.83 (2.08−3.85), ≤110 g/L:
OR (95% CI); 1.68 (1.20−2.35)) (Table 4). High Hb
concentrations were also associated with increased
odds of preeclampsia (≥120 g/L: OR (95% CI); 1.64
(1.24−2.18), ≥130 g/L: 1.34 (1.16−1.56)).
Timing. Data to examine the timing of Hb measurement were not available.
Overall estimate. Overall, low Hb (n = 8)
was significantly associated with higher odds of
preeclampsia (OR (95% CI); 1.84 (1.31−2.59)).
High Hb (n = 3) was also associated with
higher odds for preeclampsia (OR, 95% CI; 1.48
(1.10−2.01)) (Table 4).
Gestational diabetes
Hb cutoff. There are limited data examining the
association between Hb concentrations and gestational diabetes. There is a nonsignificant trend
for decreased odds of gestational diabetes associated with low Hb (≤110 g/L OR (95% CI);
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0.92 (0.73−1.16)), but based on limited data (<3
studies). On the other hand, high Hb concentrations were associated with increased odds of gestational diabetes (≥120 g/L OR (95% CI); 1.93
(1.33−2.81); ≥130 g/L; 1.71 (1.19−2.46); ≥140 g/L;
2.10 (1.65−2.68)).
Timing. Data to examine the timing of Hb measurement were not available.
Overall estimate. When all time points and cutoff values were combined, low Hb (n = 2) was not
significantly associated with increased odds of gestational diabetes, but high Hb (n = 3) was associated
with elevated odds (OR (95% CI); 2.02 (1.63−2.50))
(Table 4).
Anemia etiology
Data to examine the etiology of anemia were not
available for postpartum hemorrhage, preeclampsia, or transfusion.
Other maternal health outcomes
There were a number of maternal health outcomes of interest for which our review did not find
enough studies to conduct a meta-analysis. Outcomes included eclampsia (n = 2), infection (n =
5), prenatal depression (n = 2), postpartum depression (n = 5), other maternal morbidities (n = 3),
and maternal mortality (n = 5); summaries of these
studies (including setting, study design, sample size,
exposure, timing of exposure, and effect estimate)
may be found in Table S4 (online only).
Eclampsia
Two studies reported nonsignificant associations
between low Hb and eclampsia.31,83 Insufficient data
were available to conduct meta-analyses.
Maternal mortality
The association between maternal mortality and
maternal Hb was reviewed in the 2013 Lancet
series on maternal and child nutrition.2 The Lancet
series reported that, based on a meta-analysis of 10
studies, it is estimated that a 10 g/L greater Hb is
associated with lower odds of maternal mortality
(OR (95% CI); 0.71 (0.60−0.85)). In our review
of the literature, we found five additional articles
published since the Lancet series, with three of the
articles presenting adjusted analyses. In a Peruvian
cohort of 379,816 women, Gonzales et al. reported
increased odds of maternal mortality for women
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with Hb concentrations <70 g/L: OR (95% CI);
8.54 (2.06−35.42), 70−<90 g/L: 6.06 (3.16−11.6),
and >145 g/L: 2.01 (1.12−3.61), as compared with
women with Hb concentrations of 110−145 g/L.54
Hb was measured during the second or third
trimester and there was no significant association
with maternal mortality for women with mild
anemia (≤110 g/L). In a Scottish cohort of 80,422
singleton pregnancies with Hb concentration measured at booking (any time before birth), Rukuni
et al. found no significant association between
maternal anemia (≤100 g/L) and maternal mortality (OR (95% CI); 2.07 (0.22−9.36)).83 Most
recently, Daru et al. concluded that severe anemia
(<70 g/L) during pregnancy or postpartum doubled the odds of maternal death.122 However, the
timing of measurement is unclear and this estimate
may be an underestimation of the true effect.123
Details for these studies and the two studies presenting unadjusted analyses are available in Table S4
(online only).

Depression
Maternal depression, both during pregnancy and
postpartum, is a common condition which can also
affect the health and development of infants. Seven
studies in our review included maternal depression as an outcome. We were unable to perform
a meta-analysis due to the variation in the presentation of the prenatal or postpartum depression
outcome. Recent research conducted in India and
Ethiopia indicates an increased likelihood of prenatal depression among anemic women.124,125 A crosssectional study in Turkey of pregnant women in
their last trimester reported that anemic women
were more likely to have a higher mean depression score than nonanemic women.126 Goshtasebi
et al. found that women with anemia at delivery
were more likely to have postpartum depression
(OR (95% CI); 4.64 (1.33−16.08)).127 Raisanen et al.
and Xu et al. likewise reported that women with
anemia during pregnancy were more likely to be
diagnosed with depression.128,129 However, a crosssectional study in India of pregnant women in their
first trimester reported that depressive symptoms
were less likely to be present in anemic women compared with nonanemic women.130 Details of these
studies are included in Table S4 (online only). Overall, the majority of the research tends to show that
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maternal anemia is associated with depression and
depressive symptoms.

maternal and child outcomes among these high-risk
populations.

Other maternal morbidities
Three studies examined other maternal morbidities, of which two studies reported adjusted results.
One study examined severe maternal morbidity directly attributed to antenatal pulmonary
embolism, eclampsia, acute fatty liver of pregnancy,
amniotic fluid embolism, peripartum hysterectomy,
stroke in pregnancy, uterine rupture, placenta accreta, HELLP (hemolysis, elevated liver enzymes, low
platelet count) syndrome, or severe sepsis. A trend
for higher odds of maternal morbidity was seen
for women with Hb concentration <90 g/L during
pregnancy compared with women with Hb concentration ≥90 g/L (OR (95% CI); 1.80 (0.99−3.26)).131
A second study reported on a composite adverse
maternal outcome defined as preeclampsia, GDM,
preterm birth, PPH, puerperal morbidity, or surgical wound complication. Women with Hb concentration ≤110 g/L during pregnancy had higher
odds for this composite outcome than nonanemic
women 3.03 (1.14−8.05).132

Discussion

High-risk populations
Our review also examined the associations between
maternal Hb concentration and maternal and
child outcomes of interest in populations that are
typically at higher odds of adverse outcomes for
both mother and child. This included women with
HIV, young adolescents (<15 years), women with
preeclampsia, twin pregnancies, and other high-risk
health conditions (Table S5, online only). Eleven
studies conducted in women with HIV examined
the association between Hb concentration and
maternal mortality (n = 3), child mortality (n = 2),
preterm birth (n = 2), SGA (n = 1), preeclampsia
(n = 1), hemorrhage and transfusion (n = 1), and
asymptomatic bacteriuria (n = 1). Five studies
evaluated the relationship of maternal Hb to birth
weight (n = 5), preterm birth (n = 2), stillbirth
(n = 1), and SGA (n = 1) among young adolescents.
Two studies in women with preeclampsia examined
maternal mortality and LBW. Our review found
two studies that examined the odds of various
maternal and child outcomes in twin pregnancies.
Overall, additional research is needed to appropriately assess the role of maternal Hb concentrations
during pregnancy with regard to odds of adverse
60

Our results confirm that maternal Hb plays an
important role with regard to maternal and child
health outcomes.6–12 Low maternal Hb was associated with increased odds of poor birth outcomes
including LBW, preterm birth, SGA, stillbirth, perinatal mortality, and neonatal mortality, and adverse
maternal health outcomes, including postpartum
hemorrhage, preeclampsia, and transfusion. High
maternal Hb was likewise associated with increased
odds of poor birth outcomes (SGA and stillbirth)
and adverse maternal health outcomes (preeclampsia and gestational diabetes).
There was high heterogeneity among the studies included in the review regarding definitions of
anemia, cutoffs used for low or high Hb concentrations, and reference values used for comparison.
While this represents a challenge in interpreting
the overall results, it offered an opportunity to conduct meta-analyses comparing different cutoffs. For
LBW, PTB, stillbirth, and perinatal mortality, there
was a dose−response relationship, with associations with low Hb being nearly two times stronger
when based on the lowest cutoffs (≤70 or 80 g/L)
compared with the overall estimate (<110 g/L).
Similarly for adverse maternal outcomes, a dose
response was evident for low Hb cutoffs and odds of
postpartum hemorrhage, preeclampsia, and blood
transfusion. On the other hand, while based on
more limited data, there did not appear to be a
dose response with elevated cutoffs for high Hb
and birth outcomes or adverse maternal health outcomes. The exception was a stillbirth where elevated
cutoffs (≥140 g/L) were associated with increased
odds of stillbirth compared with the overall estimate
for high maternal Hb (>130 g/L).
The associations between maternal Hb and
maternal and child outcomes varied by the timing
of the assessment. Studies were categorized based
on whether maternal Hb was measured during the
preconception period, or in the first, second, or
third trimester of pregnancy. Our search identified
only four papers on maternal preconception Hb
and birth outcomes.17,82,98,111 Low Hb concentration during preconception was associated with
increased odds of LBW and SGA. During the first
trimester, low Hb was associated with increased
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odds of LBW, PTB, and neonatal mortality (results
were nonsignificant but followed similar trends for
overall estimates for other outcomes). There were
limited data on preconception and first trimester
high Hb and birth outcomes with many comparisons having fewer than three studies. Results that
are specific to Hb preconception and in the first
trimester are particularly useful because they may
have important implications for the timing and
delivery of maternal interventions and prenatal
care. There were comparably fewer studies with Hb
measured during the second trimester compared
to the first or third trimester of pregnancy. Low
maternal Hb concentration assessed during the
second trimester was not associated with LBW,
SGA, or perinatal mortality, which is in contrast
to the significant associations reported for overall
pregnancy estimates. Conversely, a significant association between high maternal Hb concentration
and increased odds of LBW and SGA was found
only during the second trimester and results for
other trimesters were nonsignificant or in an opposite direction (e.g., LBW in the third trimester).
However, data for trimester-specific comparisons
regarding high Hb were limited (<3 studies) and
thus this issue merits further research. The second
trimester is of particular importance in reviewing
the cutoffs for anemia, given changes in blood
volume and variation in recommendations for Hb
cutoffs during this period. In the third trimester,
low maternal Hb was associated with LBW and
PTB but not SGA, perinatal mortality, or stillbirth.
In contrast, high maternal Hb was associated with
greater odds of stillbirth. Further research is needed
to confirm these findings and understand the mechanisms that may underlie differential associations
based on the timing of Hb assessment.
The key strength of this review and meta-analyses
is the broad scope of health outcomes included for
both the mother and child. Additional strengths
include separate analyses by Hb concentration cutoff and timing of measurement. There are also a
number of limitations of this review. Given the
U-shaped curve of the relationship between maternal Hb and adverse birth outcomes,5 we were not
able to conduct meta-analyses using continuous
variables for Hb. We were unable to assess the shape
of relationships and determine possible points of
inflection (e.g., data-driven cutoffs) as this would
require access to individual-level data. There was
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also variation in statistical measures used across
studies, which limited the studies available for our
meta-analyses. Another limitation in the interpretation of the overall estimates during pregnancy
is that studies that provided results using multiple Hb concentration cutoffs were included more
than once and thus were more heavily weighted.
We chose to include all data and cutoffs available
given the goal of providing insight on Hb cutoffs in
relation to health outcomes. There was also variation across studies in the reference group used for
comparisons. Some studies compared low Hb to
a normal range of Hb values, while others compared anemic to nonanemic women. The latter is
potentially problematic as the nonanemic category
(e.g., Hb ≥ 110 g/L) also includes individuals with
high Hb and may bias results to the null. Likewise,
for some lower cutoff values for Hb, the comparison group (e.g., Hb ≥ 90 g/L) included individuals with mild/moderate anemia, “healthy values,”
and high Hb; which may further attenuate results.
In addition, among studies that included a reference range, there was little consensus across studies
on the range to use (e.g., 110−119 or 115.3−133.3
or 110−145 g/L). This makes direct comparisons
and pooling of results for meta-analysis difficult;
however, we chose to include all data and comparisons since the goal of our review was to
provide a landscape of existing literature. Given
this limitation, results should be interpreted with
caution, as it is possible that they are underestimates of the association of anemia with poor
outcomes.
Several research gaps were identified through this
review (highlighted in Table 5). There were insufficient data reported on anemia etiology to examine
if associations between anemia and maternal and
child outcomes vary by the cause of anemia. Given
the diverse etiology of anemia across the globe, this
is an important research gap. In addition to IDA,
anemia due to other causes including malaria, infection, hemoglobinopathies, or other nutrient deficiencies should be examined. In addition, data were
insufficient to conduct meta-analyses on certain key
outcomes of interest. In particular, data were limited
to maternal health outcomes (e.g., depression) and
long-term child health outcomes (e.g., cardiovascular outcomes, diabetes, and child development). In
addition, further research among certain high-risk
populations (young pregnant adolescents and twin
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Table 5. Key priority areas of research
Key priority areas of research

r It remains unclear how the relationship between anemia and maternal and child outcomes may vary based on the cause of
anemia and potential implications for anemia cutoffs.

r Additional research is required to better understand the association of maternal Hb with maternal outcomes (e.g., depression)
and long-term child health outcomes (e.g., cardiovascular outcomes, diabetes, and child development).

r Few studies report relationships between continuous measures of maternal Hb and health outcomes.
r Further research is required on the role of maternal preconception Hb and birth outcomes.
r Few studies provide maternal Hb data during multiple time periods during pregnancy in the same cohort of women. This
information is needed to guide potential trimester-specific cutoff decisions.

r Limited data are available in high-risk populations and further research is needed to understand if separate cutoffs are needed
(i.e., twin pregnancies).

r Pooled, high-quality, individual-level prospective cohort data are needed to conduct cutoff analysis to inform the reevaluation
of Hb cutoffs during pregnancy.

pregnancies) would be beneficial in determining if
separate cutoffs may be required.
Data on the specific timing of measurement were
lacking in many of the studies assessed and there
was a particular gap during preconception and
the second trimester of pregnancy. Ideally, prospective cohort data with maternal Hb values at multiple
time periods across the continuum of preconception, pregnancy, and postpartum would allow us
to better assess the role of the timing and guide
potential trimester-specific cutoff decisions. While
it was beyond the scope of the current review, the
association between postpartum maternal Hb and
maternal and child health outcomes may also merit
further examination, including a possible relationship between maternal anemia during lactation
and breastmilk macronutrient composition.133
Furthermore, the majority of the literature that
examines the role of the timing on health outcomes
has focused on low Hb. Critical gaps remain regarding the importance of the timing of measurement
of high Hb concentrations with respect to adverse
outcomes. Interpretation of high Hb concentrations
is complicated by a lack of data on plasma volume
expansion. Failure of maternal plasma volume
expansion has been associated with several adverse
pregnancy outcomes as well as elevated Hb concentration. For certain outcomes like preeclampsia and
gestational diabetes, where plasma volume changes
are related to the condition, interpretation of Hb
concentrations is more difficult. Future studies
to address this gap should include biomarkers
of iron status, inflammation, and blood volume

62

expansion to better elucidate the etiology of these
relationships.134,135
Conclusions
The goal of this review was to provide a comprehensive overview of the literature on the association of maternal Hb concentration with maternal and child health outcomes. Our findings support the importance of ensuring that maternal Hb
remains in a healthy range during pregnancy as
both low and high Hb concentrations were associated with poor birth outcomes. However, current
data alone are insufficient for determining if revisions are needed to current Hb cutoffs. A number
of key gaps in the literature have been identified
as research priority areas (Table 5). In particular,
pooled high-quality individual-level data analyses,
as well as prospective cohort studies that measure
Hb during preconception and across pregnancy,
would be valuable to inform the reevaluation of Hb
cutoffs.
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